SPRY
ARS Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.11
−0.96%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.79x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 32.67x
- Price / sales
- 3.50x
- Price / cash flow
- -2.08x
Enterprise value
- Enterprise value
- $436.5M
- EV / sales
- 3.73x
- EV / EBITDA
- -2.11x
- EV / EBIT
- -2.02x
- Market cap
- $408.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026